Company Filing History:
Years Active: 2013
Title: Kenneth P. Leclair: Innovator in Herpes Virus Treatment
Introduction
Kenneth P. Leclair is a notable inventor based in Needham, MA (US). He has made significant contributions to the field of medical science, particularly in the development of vaccines for viral infections. His work focuses on innovative methods for the prevention and treatment of herpes simplex virus infections.
Latest Patents
Kenneth P. Leclair holds a patent for a vaccine aimed at the treatment and prevention of herpes simplex virus infection. The patent describes methods and compositions that utilize antigenic peptides and pharmaceutical compositions. These compositions include complexes of antigenic peptides and adjuvants that can activate an immune response against herpes viruses. The invention also outlines methods for producing these antigenic peptides and their complexes, as well as the pharmaceutical applications of these compositions.
Career Highlights
Kenneth P. Leclair has been associated with Agenus Inc., a company dedicated to advancing immunotherapy and vaccine development. His work at Agenus Inc. has been pivotal in pushing the boundaries of vaccine research and development.
Collaborations
Throughout his career, Kenneth has collaborated with esteemed colleagues, including Alemseged Truneh and Daniel Lewis Levey. These collaborations have contributed to the advancement of research in the field of immunology and vaccine development.
Conclusion
Kenneth P. Leclair's innovative work in the field of herpes virus treatment exemplifies the impact of dedicated research and collaboration in medical science. His contributions continue to pave the way for advancements in vaccine technology and infectious disease prevention.